(alpha-carboxycyclopropyl)glycine (CCPG)

Subscribe to Selected New Research on (alpha-carboxycyclopropyl)glycine

5 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Description: structure given in first source; glutamate receptor agonist

Also Known As:

CCPG; (alpha-carboxycyclopropyl)glycine, (1R-(1alpha(S*),2alpha))-isomer; (alpha-carboxycyclopropyl)glycine, (1R-(1alpha(S*),2beta))-isomer; (alpha-carboxycyclopropyl)glycine, (1S-(1alpha(R*),2alpha))-isomer; (alpha-carboxycyclopropyl)glycine, (1S-(1alpha(R*),2beta))-isomer; 2-(carboxycyclopropyl)glycine; 3,4-cyclopropylglutamate; L-2-(carboxypropyl)glycine; L-CCG III; L-CCG-I; alpha-(carboxycyclopropyl)glycine; Cyclopropaneacetic acid, alpha-amino-2-carboxy-

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins

Amino Acids: 8523

Dicarboxylic Amino Acids: 20

(alpha-carboxycyclopropyl)glycine: 5

Related Diseases

1.	Seizures (Seizure) 02/19/1999 - "While DHPG (400 nmoles) induced EEG and behavioural limbic seizures, L-CCG-I (400 nmoles) and L-AP4 (800 nmoles) induced a 'depressant' EEG with an increase in relative power in the slow-frequency bands and a decrease in relative power in the high-frequency bands) and behavioural effects" 03/19/1999 - "Pretreatment i.c.v. with a presynaptic mGlu receptor agonist (the group 2 mGlu receptor agonist (2S,1'S,2'S)-2-(carboxycyclopropyl)-glycine (L-CCG-I: 3.0 and 5.6 nmol) and the group 3 mGlu receptor agonist, L-amino-4-phosphonobutyric acid (L-AP4: 3.0 and 5.6 nmol)) failed to suppress the decrease in seizure threshold in diazepam-withdrawn mice, but increased the seizure threshold in control mice" Get all the results and reference details, order at left...
2.	Hyperalgesia 09/01/2002 - "Intrathecal administration of the group II mGluR agonist (2S,1S,2S)-2-(carboxycyclopropyl)glycine (L-CCG-I; 620 nmol) given either before or after carrageenan treatment produced analgesia and anti-hyperalgesia, an effect abolished by co-administration of EGLU (570 nmol)" Get all the results and reference details, order at left...
3.	Gambling (Pathological Gambling) 01/01/2005 - "The characteristics of problem gamblers calling the Connecticut Council on Problem Gambling (CCPG) gambling helpline during the years 2000-2001 (n = 960) were examined based on the presence or absence of self-reported alcohol use problems" Get all the results and reference details, order at left...
4.	Catalepsy 08/28/1998 - "The group II agonist (2S,3S,4S)-alpha-carboxycyclopropyl-glycine (L-CCG I) dose dependently induced catalepsy, infused intracerebroventricular (i.c.v.) in rats" Get all the results and reference details, order at left...
4 Diseases and 5 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Glycine (Aminoacetic Acid)
2.	Diazepam (Valium)
3.	Carrageenan
4.	Carbon Monoxide
5.	dihydroxyphenylethylene glycol
5 Drugs and Important Bio-Agents and 3 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Analgesia
1 Therapies and Procedures and 1 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>